Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada

Introduction: The expensive modern therapeutic regimens for advanced lung cancer (LC) stages have been recently approved. We evaluated whether low-dose computed tomography (LDCT) LC screening of high-risk Albertans is cost saving. Methods: We used a decision analytical modeling technique with a heal...

Full description

Bibliographic Details
Main Authors: Nguyen Xuan Thanh, MD, PhD, Truong-Minh Pham, MD, PhD, Arianna Waye, PhD, Alain Tremblay, MDCM, Huiming Yang, MD, Michelle L. Dean, BSc, Tracy Wasylak, MSc, Randeep Sangha, MD, Douglas Stewart, MD
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:JTO Clinical and Research Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322000741